Baijin Life Science (HKG:1466) completed the allotment and issue of 65,359,433 shares to 20 subscribers at HK$0.48 apiece, raising net proceeds of around HK$31.3 million, a Thursday filing with the Hong Kong bourse said.
The jewelry business will use proceeds from the issue for general working capital.
Price (HKD): $0.70, Change: $+0.020, Percent Change: +2.94%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。